Crispr Therapeutics shares owned by Riggs Asset Managment
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Riggs Asset Managment
from 13F filings
Historical chart of Riggs Asset Managment investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by Riggs Asset Managment consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Crispr Therapeutics by Riggs Asset Managment
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-12-31 | $16k | 400 | 38.65 |
| 2024-09-30 | $19k | 400 | 46.98 |
| 2024-06-30 | $27k | 500 | 54.01 |
| 2024-03-31 | $34k | 500 | 68.16 |
| 2023-12-31 | $19k | 300 | 62.60 |
| 2023-09-30 | $4.5k | 100 | 45.39 |
| 2023-06-30 | $5.6k | 100 | 56.14 |